z-logo
open-access-imgOpen Access
Rivaroxaban in prevention of stroke in elderly patients with non-valvular atrial fibrillation
Author(s) -
I. S. Yavelov
Publication year - 2020
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.n892
Subject(s) - rivaroxaban , atrial fibrillation , medicine , warfarin , stroke (engine) , cardiology , randomized controlled trial , mechanical engineering , engineering
Data regarding efficacy and safety of direct oral anticoagulant rivaroxaban in prevention of stroke in elderly polymorbid patients with non-valvular atrial fibrillation are presented. In this aspect results of randomized clinical trial in direct comparison of rivaroxaban and warfarin in patients with non-valvular atrial fibrillation ROCKET-AF are discussed. Results of rivaroxaban use in elderly patients in real medical practice are also considered.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here